Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessThe role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
Despite modern advances in cancer medicine, pancreatic cancer survival remains unchanged at just 12%. For the small proportion of patients diagnosed with ‘early’ (upfront or borderline resectable) disease, rec...